AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32809136 — intervention group
Group type: COMPARATOR
Intervention: Usual oxygen therapy
Number of subjects: 166
Study 34957992 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined handheld ultrasound and fluoroscopy-guided corticosteroid injection
Number of subjects: 39
Study 34957992 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound-guided corticosteroid injection
Number of subjects: 39
Study 32897182 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization
Number of subjects: 50
Study 32897182 — intervention group
Group type: COMPARATOR
Intervention: Splinting
Number of subjects: 50
Study 36235865 — intervention group
Group type: EXPERIMENTAL
Intervention: FibreMAX (two daily servings of 25 g of BARLEYmax®)
Number of subjects: 38
Study 36235865 — intervention group
Group type: EXPERIMENTAL
Intervention: FibreGRAD (two daily servings with the amount of fibre gradually increased)
Number of subjects: 38
Study 36235865 — intervention group
Group type: COMPARATOR
Intervention: Control (two daily servings totalling 25 g of placebo product)
Number of subjects: 38
Study 33883012 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision-Making (SDM) approach
Number of subjects: 9
Study 33883012 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment strategies informed by Theoretical Domains Framework (TDF)
Number of subjects: 9
Study 33883012 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment practices
Number of subjects: 9
Study 32140704 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement 10 µg
Number of subjects: 206
Study 32140704 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement 25 µg
Number of subjects: 206
Study 32140704 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 µg)
Number of subjects: 206
Study 34663910 — intervention group
Group type: EXPERIMENTAL
Intervention: First-language instruction
Number of subjects: 230
Study 34663910 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 230
Study 34704722 — intervention group
Group type: EXPERIMENTAL
Intervention: Oblique (OB) approach
Number of subjects: 147
Study 34704722 — intervention group
Group type: COMPARATOR
Intervention: Anteroposterior (AP) approach
Number of subjects: 147
Study 34270620 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mA of anodal tDCS stimulation over the left dorsolateral prefrontal cortex for 20 minutes
Number of subjects: 48
Study 34270620 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 48
Study 33065547 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG (500, 1500, and 5000 IU)
Number of subjects: 0
Study 33065547 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned medium (CM) from human endometrial stromal cells (ESC) stimulated with hCG
Number of subjects: 0
Study 33065547 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 36355053 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU)
Number of subjects: 55
Study 36355053 — intervention group
Group type: COMPARATOR
Intervention: Placebo (first year) then Testosterone undecanoate (TU) (second year)
Number of subjects: 55
Study 33213492 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) applied with 15–25% tension for 72 hours
Number of subjects: 30
Study 33213492 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping without tension
Number of subjects: 30
Study 34702946 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs)
Number of subjects: 58
Study 33232454 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary Computed Tomography (CCT)
Number of subjects: 1980
Study 33232454 — intervention group
Group type: COMPARATOR
Intervention: Stress Echocardiography (SE)
Number of subjects: 1980
Study 35165819 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (NAVA)
Number of subjects: 8
Study 35165819 — intervention group
Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 8
Study 33492484 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based surgical skill learning session (WSSL)
Number of subjects: 62
Study 33492484 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face tutorials (control group)
Number of subjects: 62
Study 32164771 — intervention group
Group type: EXPERIMENTAL
Intervention: CareConekta app plus text notifications and phone calls and/or WhatsApp messages
Number of subjects: 200
Study 35339294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led couples intervention plus routine nursing care
Number of subjects: 104
Study 35339294 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 104
Study 33478426 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaco-UCP
Number of subjects: 61
Study 33478426 — intervention group
Group type: COMPARATOR
Intervention: Phaco-along
Number of subjects: 61
Study 32470921 — intervention group
Group type: EXPERIMENTAL
Intervention: PABC discussion session
Number of subjects: 50
Study 32470921 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 35925203 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐Ach (beta‐3 agonists)
Number of subjects: 12
Study 35925203 — intervention group
Group type: COMPARATOR
Intervention: Anticholinergic
Number of subjects: 12
Study 33825049 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR score
Number of subjects: 3878
Study 32879152 — intervention group
Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 28
Study 32879152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 32879152 — intervention group
Group type: EXPERIMENTAL
Intervention: Selexipag (in patients not using a pulmonary vasodilator)
Number of subjects: 28
Study 32928020 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective catheterization of bilateral uterine arteries and subsequent uterine embolization (EMB)
Number of subjects: 76
Study 32928020 — intervention group
Group type: COMPARATOR
Intervention: Elective cesarean section (CTR)
Number of subjects: 76
Study 33512251 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey-lemon spray
Number of subjects: 46
Study 33512251 — intervention group
Group type: COMPARATOR
Intervention: Benzydamine hydrochloride spray
Number of subjects: 46
Study 32315362 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention for obesity and depression
Number of subjects: 204
Study 32315362 — intervention group
Group type: COMPARATOR
Intervention: Poor engagement in the intervention
Number of subjects: 204
Study 35652933 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care with focus group participation
Number of subjects: 18
Study 35652933 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 18
Study 34045081 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime‐Avibactam (CAZ‐AVI)
Number of subjects: 0
Study 34045081 — intervention group
Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 0
Study 35636516 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-app group (iApp) using mobile cognitive training for 12 days (T0 to T1)
Number of subjects: 47
Study 35636516 — intervention group
Group type: COMPARATOR
Intervention: Delayed-app group (dApp) starting mobile cognitive training at T1 for 12 days (T1 to T2)
Number of subjects: 47
Study 33715382 — intervention group
Group type: EXPERIMENTAL
Intervention: TR‐PH (fixed-combination tropicamide 1% and phenylephrine 2.5%)
Number of subjects: 131
Study 33715382 — intervention group
Group type: EXPERIMENTAL
Intervention: PH (phenylephrine 2.5%)
Number of subjects: 131
Study 33715382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 33715382 — intervention group
Group type: EXPERIMENTAL
Intervention: TR (tropicamide 1%)
Number of subjects: 131
Study 33020047 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforce Transverse Appliance (TTA)
Number of subjects: 36
Study 33020047 — intervention group
Group type: EXPERIMENTAL
Intervention: NiTi Palatal Expander (NPE)
Number of subjects: 36
Study 33020047 — intervention group
Group type: COMPARATOR
Intervention: Control Group (historical)
Number of subjects: 36
Study 34609359 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered pain management program with optional clinician support
Number of subjects: 659
Study 34609359 — intervention group
Group type: COMPARATOR
Intervention: Control (waitlist-control group)
Number of subjects: 659
Study 34609359 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered pain management program
Number of subjects: 659
Study 33097567 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib and cediranib
Number of subjects: 618
Study 33097567 — intervention group
Group type: COMPARATOR
Intervention: Olaparib alone
Number of subjects: 618
Study 35553560 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat Therapy (HT) at 39ºC for 30 min/day, 5 days/week during 3 consecutive weeks
Number of subjects: 24
Study 35553560 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat Therapy (HT) at 39ºC for 3 weeks
Number of subjects: 24
Study 35553560 — intervention group
Group type: COMPARATOR
Intervention: Control group (room temperature)
Number of subjects: 24
Study 35027944 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES + rTMS
Number of subjects: 240
Study 35027944 — intervention group
Group type: COMPARATOR
Intervention: NMES
Number of subjects: 240
Study 35027944 — intervention group
Group type: COMPARATOR
Intervention: rTMS
Number of subjects: 240
Study 35027944 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study 32169595 — intervention group
Group type: EXPERIMENTAL
Intervention: Elongated containers
Number of subjects: 0
Study 32169595 — intervention group
Group type: COMPARATOR
Intervention: Subsequently encountered food
Number of subjects: 0
Study 33051727 — intervention group
Group type: EXPERIMENTAL
Intervention: mTICCS
Number of subjects: 30
Study 32878869 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made insole
Number of subjects: 185
Study 32878869 — intervention group
Group type: COMPARATOR
Intervention: Sham insole
Number of subjects: 185
Study 32878869 — intervention group
Group type: COMPARATOR
Intervention: GP-led usual care
Number of subjects: 185
Study 35780013 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-related images
Number of subjects: 113
Study 35780013 — intervention group
Group type: EXPERIMENTAL
Intervention: Implied and actual penetrative sex images
Number of subjects: 113
Study 32398160 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen plus intravenous acetaminophen (NOO-A)
Number of subjects: 684
Study 32398160 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 684
Study 616882823 — intervention group
Group type: EXPERIMENTAL
Intervention: Kistinox Forte, 1 sachet per day during the first 10 days of the month for 3 months
Number of subjects: 150
Study 616882823 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 150
Study 32358638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent stimulation of the auricular branch of vagus nerve using neurostimulator V (Ducest®, Germany), starting 24 hours preoperatively and continued till the 4th postoperative day.
Number of subjects: 100
Study 32358638 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation).
Number of subjects: 100
Study 36064727 — intervention group
Group type: EXPERIMENTAL
Intervention: TOPSY self-management intervention including a self-management support session with a pessary practitioner, a follow-up phone call 2 weeks later, and ongoing support as needed.
Number of subjects: 0
Study 36064727 — intervention group
Group type: EXPERIMENTAL
Intervention: TOPSY self-management intervention
Number of subjects: 0
Study 34190015 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 7149
Study 34190015 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 7149
Study 34190015 — intervention group
Group type: COMPARATOR
Intervention: Nomogram compared to TNM stage and SEER stage
Number of subjects: 7149
Study 34190015 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curves for OS and CSS
Number of subjects: 7149
Study 32907433 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control with glycemic targets of fasting blood glucose (FBG) <130 mg/dL, postprandial BG <180 mg/dL, and HbA1c <8%, using a basal-bolus insulin regimen and frequent titration of insulin.
Number of subjects: 0
Study 32907433 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose control with prior treatment (oral antidiabetic drugs) with no titration unless meeting rescue criteria.
Number of subjects: 0
Study 34391759 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose radiation therapy (LDRT) of 0.5 Gy to bilateral whole lungs
Number of subjects: 25
Study 34251534 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral irrigator + toothbrush (OI group, n=15)
Number of subjects: 45
Study 34251534 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral irrigator + toothbrush (OI group)
Number of subjects: 45
Study 34251534 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdental brush + toothbrush (IB group, n=15)
Number of subjects: 45
Study 34251534 — intervention group
Group type: COMPARATOR
Intervention: Toothbrush only (C group, n=15)
Number of subjects: 45
Study 33709528 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV and call center
Number of subjects: 20
Study 33709528 — intervention group
Group type: COMPARATOR
Intervention: NIV alone
Number of subjects: 20
Study 35552067 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance breathing (set at -7 cm.H2O) during LBNP
Number of subjects: 5
Study 35552067 — intervention group
Group type: COMPARATOR
Intervention: Control condition (LBNP at 3 mmHg/min)
Number of subjects: 5
Study 36314277 — intervention group
Group type: COMPARATOR
Intervention: Tocilizumab
Number of subjects: 176
Study 33827834 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Communication Education (ACE) programme plus treatment‐as‐usual
Number of subjects: 12
Study 33827834 — intervention group
Group type: COMPARATOR
Intervention: treatment‐as‐usual only (control group)
Number of subjects: 12
Study 32546992 — intervention group
Group type: EXPERIMENTAL
Intervention: MKP (Met-Lys-Pro)
Number of subjects: 268
Study 32546992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study 35987195 — intervention group
Group type: EXPERIMENTAL
Intervention: Human-milk-based fortifiers (HMBF)
Number of subjects: 119
Study 35987195 — intervention group
Group type: COMPARATOR
Intervention: Bovine-milk-based fortifiers (BMBF)
Number of subjects: 119
Study 35987195 — intervention group
Group type: EXPERIMENTAL
Intervention: HMBF
Number of subjects: 119
Study 33972379 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-directed fast-food advertisements with premiums present
Number of subjects: 28
Study 33972379 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery of premiums in advertisements
Number of subjects: 28
Study 32396917 — intervention group
Group type: EXPERIMENTAL
Intervention: CCBT using the Good Days Ahead program (up to 5.5 h of therapist contact)
Number of subjects: 154
Study 32396917 — intervention group
Group type: COMPARATOR
Intervention: Standard CBT (up to twenty 50-min sessions)
Number of subjects: 154
Study 36465612 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangfudaotan (CFDT) decoction
Number of subjects: 40
Study 36465612 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 40
Study 36465612 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal-fat diet and saline)
Number of subjects: 40
Study 36465612 — intervention group
Group type: COMPARATOR
Intervention: PCOS group (high-fat diet and letrozole)
Number of subjects: 40
Study 32168417 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound acupuncture (pulsed therapeutic ultrasound at 1 MHz for 5 minutes per point daily for 12 days)
Number of subjects: 17
Study 32168417 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound acupuncture
Number of subjects: 17
Study 35446760 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient Diversity (GradDiv) regularizations
Number of subjects: 0
Study 33347666 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (fraction of inspired O2 = 0.117)
Number of subjects: 27
Study 33347666 — intervention group
Group type: COMPARATOR
Intervention: Normobaric normoxia (fraction of inspired O2 = 0.21)
Number of subjects: 27
Study 32930918 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 532
Study 32930918 — intervention group
Group type: EXPERIMENTAL
Intervention: Acculturative stress (youth's own)
Number of subjects: 532
Study 35150943 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitooligosaccharide (COS) 15 mg/kg
Number of subjects: 360
Study 34011674 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab
Number of subjects: 300
Study 34011674 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 300
Study 35218559 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (TER; 4 mg × day-1, n = 13)
Number of subjects: 21
Study 35218559 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA, n = 8)
Number of subjects: 21
Study 34673918 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional task exercise
Number of subjects: 145
Study 34673918 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 145
Study 34673918 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 145
Study 34673918 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 145
Study 33524284 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary ED-based fall prevention intervention
Number of subjects: 0
Study 33524284 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 36161487 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Clinical Trial (RCT) with historical control data
Number of subjects: 0
Study 36161487 — intervention group
Group type: COMPARATOR
Intervention: Standard (control) treatment
Number of subjects: 0
Study 33136253 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led prescribing (intervention)
Number of subjects: 84
Study 33136253 — intervention group
Group type: COMPARATOR
Intervention: Conventional prescribing (control)
Number of subjects: 84
Study 32348797 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy restricted diet providing 25% (691 (42) kcal) of estimated energy requirements
Number of subjects: 14
Study 32348797 — intervention group
Group type: COMPARATOR
Intervention: Energy balanced diet providing 100% (2755 (159) kcal) of estimated energy requirements
Number of subjects: 14
Study 35763050 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 293
Study 35763050 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 293
Study 35763050 — intervention group
Group type: EXPERIMENTAL
Intervention: Total costs of secondary care
Number of subjects: 293
Study 33475222 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 0
Study 33475222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32192905 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide and silver cations, physical separation, and compartmentalization of ICU
Number of subjects: 738
Study 36120781 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mg/d Donepezil Transdermal Delivery System (TDS)
Number of subjects: 60
Study 36120781 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mg/d Donepezil Transdermal Delivery System (TDS)
Number of subjects: 60
Study 36120781 — intervention group
Group type: COMPARATOR
Intervention: Oral Donepezil (10-mg/d)
Number of subjects: 60
Study 33970899 — intervention group
Group type: EXPERIMENTAL
Intervention: MRL prediction model using frame pooling for 5'UTRs of any length
Number of subjects: 0
Study 33970899 — intervention group
Group type: EXPERIMENTAL
Intervention: 5'UTR variant of the gene HBB associated with beta‐thalassemia
Number of subjects: 0
Study 34612846 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tocilizumab 8 mg/kg
Number of subjects: 437
Study 34612846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study 33359595 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma
Number of subjects: 27
Study 33359595 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 27
Study 34192714 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (n=90)
Number of subjects: 183
Study 34192714 — intervention group
Group type: COMPARATOR
Intervention: Pain education (n=93)
Number of subjects: 183
Study 35361636 — intervention group
Group type: EXPERIMENTAL
Intervention: Group biofeedback treatment, psycho‐education and treatment as usual (TAU)
Number of subjects: 68
Study 35361636 — intervention group
Group type: COMPARATOR
Intervention: Psycho‐education and TAU only
Number of subjects: 68
Study 35361636 — intervention group
Group type: EXPERIMENTAL
Intervention: Group biofeedback treatment, psycho‐education and TAU
Number of subjects: 68
Study 34076665 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (CVD risk reduction model)
Number of subjects: 125436
Study 32706698 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention using the KELA.AE app
Number of subjects: 23
Study 35107439 — intervention group
Group type: EXPERIMENTAL
Intervention: COPe-support (Carers fOr People with Psychosis e‐support), a psychoeducational intervention delivered via a web‐based platform for 8 months.
Number of subjects: 35
Study 35107439 — intervention group
Group type: EXPERIMENTAL
Intervention: COPe-support
Number of subjects: 35
Study 33222210 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive training group (N = 27)
Number of subjects: 56
Study 33222210 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 29)
Number of subjects: 56
Study 36171543 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site trauma surgeon
Number of subjects: 58
Study 33705179 — intervention group
Group type: EXPERIMENTAL
Intervention: Protecting Strong African American Families (ProSAAF) program
Number of subjects: 295